ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

42,927Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 6645

$4.37M Total Retail Price of All Prescriptions

Rank: 7 out of 6645

571 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
100% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 571 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

19% of this provider’s 571 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 37,650 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

54% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$102 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

75 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
ADVAIR DISKUS 1,239 1,057 1 45
NEXIUM 1,170 999 2 40
SINGULAIR 952 831 3 76
ZETIA 889 777 10 4 87
NAMENDA 852 741 5 41
ZOLPIDEM TARTRATE 831 694 6 17
LOVAZA 745 621 7 68
DIOVAN 733 591 8 19
ATENOLOL 700 610 9 8
ATORVASTATIN CALCIUM 676 608 10 10
LIDODERM 631 588 11 53
TERAZOSIN HCL 627 573 10 12 48
DIOVAN HCT 619 537 13 64
PLAVIX 616 541 14 49
DONEPEZIL HCL 611 536 15 27
EXELON 601 533 16 149
IBUPROFEN 591 486 17 42
METFORMIN HCL 590 486 18 7
AVODART 586 513 19 99
NAPROXEN 565 552 20 88
CYMBALTA 552 477 21 78
AMLODIPINE BESYLATE 547 508 22 2
CRESTOR 535 462 23 34
DIGOXIN 528 497 24 59
MECLIZINE HCL 526 446 25 122
ABILIFY 525 474 26 204
TRILIPIX 518 445 10 27 178
GLYBURIDE 515 477 R 28 58
TRAMADOL HCL 505 454 29 30
CELEBREX 497 453 30 54
ALENDRONATE SODIUM 486 464 31 14
SIMVASTATIN 481 400 32 1
DEXILANT 478 411 33 102
HYDROCODONE-ACETAMINOPHEN 460 355 S3 34 5
TAMSULOSIN HCL 456 410 35 22
PATANOL 439 383 36 131
METOPROLOL SUCCINATE 418 378 37 24
OMEPRAZOLE 409 350 38 6
CLOPIDOGREL 404 363 39 36
FUROSEMIDE 397 365 40 11
ISOSORBIDE MONONITRATE ER 392 381 41 66
SPIRIVA 379 325 42 65
JANUVIA 362 298 43 38
NASONEX 357 311 44 126
LEVOTHYROXINE SODIUM 340 302 45 4
CILOSTAZOL 328 316 46 202
LIPITOR 327 292 47 69
VESICARE 325 279 48 148
TRIAMCINOLONE ACETONIDE 325 305 48 55
POTASSIUM CHLORIDE 314 298 50 28
GLIMEPIRIDE 297 241 51 47
MONTELUKAST SODIUM 292 235 52 128
DETROL LA 283 246 10 53 260
AMLODIPINE BESYLATE-BENAZEPRIL 269 258 54 97
ACTONEL 268 257 55 92
CARVEDILOL 256 216 56 25
LISINOPRIL 252 219 57 3
FENOFIBRATE 251 239 58 74
FLUOCINONIDE 246 222 59 130
PROAIR HFA 232 181 60 32
FLUTICASONE PROPIONATE 230 184 61 26
SUMATRIPTAN SUCCINATE 226 187 10 62 306
METOPROLOL TARTRATE 222 189 63 13
ACTOS 222 185 63 71
LOSARTAN-HYDROCHLOROTHIAZIDE 222 218 63 62
INSULIN SYRINGE 217 177 66 61
SYMBICORT 215 166 67 153
VOLTAREN 211 192 68 108
BENAZEPRIL HCL 208 178 69 21
ACIPHEX 195 192 70 167
TRICOR 191 163 71 138
NATEGLINIDE 183 155 72 220
MELOXICAM 183 149 72 46
DICLOFENAC SODIUM 176 152 74 109
ACETAMINOPHEN-CODEINE 173 169 S3 75 80
COMBIVENT 172 152 76 174
HUMULIN 70-30 156 142 77 328
HYDROCHLOROTHIAZIDE 155 139 78 9
LOSARTAN POTASSIUM 153 140 79 12
DILTIAZEM 24HR CD 152 122 80 176
LANTUS 151 110 81 50
GLYBURIDE-METFORMIN HCL 148 128 R 82 95
OXYCODONE HCL 143 101 S2 83 162
SERTRALINE HCL 139 94 84 43
ENALAPRIL MALEATE 133 128 85 75
CLONIDINE HCL 131 98 86 56
NOVOLIN 70-30 129 118 87 309
ISOSORBIDE DINITRATE 129 114 87 200
GABAPENTIN 129 110 87 18
COLCRYS 125 123 90 192
SINGLE USE SWAB 125 122 90 350
PANTOPRAZOLE SODIUM 123 116 92 29
JANUMET 123 112 92 132
LANSOPRAZOLE 122 114 94 163
KLOR-CON 8 122 110 94 123
BONIVA 115 95 96 191
PAROXETINE HCL 113 97 97 72
OLANZAPINE 111 105 98 140
OXYBUTYNIN CHLORIDE 105 103 99 129
BENICAR 105 75 99 84
SURE COMFORT 98 88 101 358
ESCITALOPRAM OXALATE 95 92 102 86
ALCOHOL SWABS 94 85 103 319
VENTOLIN HFA 93 80 104 146
ARICEPT 93 84 104 442
NITROSTAT 91 88 106 193
ENABLEX 91 91 106 301
RAMIPRIL 90 87 108 118
ZOLPIDEM TARTRATE ER 88 76 109 500
CARISOPRODOL 88 42 R 109 94
LEXAPRO 84 75 111 218
PATADAY 82 74 112 183
VYTORIN 82 81 112 170
GEMFIBROZIL 80 78 114 96
AZITHROMYCIN 79 69 115 44
XOPENEX HFA 77 58 116 345
BYSTOLIC 76 76 117 110
COREG CR 74 70 118 242
GLIPIZIDE 74 69 118 23
FAMOTIDINE 73 56 120 33
QUETIAPINE FUMARATE 73 36 120 101
SEROQUEL 70 47 122 208
SEROQUEL XR 68 47 123 343
METOCLOPRAMIDE HCL 66 51 124 120
BUSPIRONE HCL 65 57 125 207
IBANDRONATE SODIUM 62 52 126 147
PRAMIPEXOLE DIHYDROCHLORIDE 61 61 127 222
AMIODARONE HCL 61 43 127 160
ALLOPURINOL 61 61 127 31
OXYBUTYNIN CHLORIDE ER 60 60 130 179
PRAVASTATIN SODIUM 60 60 130 20
AMOXICILLIN 55 46 132 107
THEOPHYLLINE ANHYDROUS 55 55 132 253
SULFASALAZINE 55 52 132 459
FLUOXETINE HCL 55 43 132 63
WARFARIN SODIUM 54 47 136 16
VENLAFAXINE HCL ER 54 47 136 175
AMITIZA 54 51 136 245
EFFIENT 51 49 139 261
PROPRANOLOL HCL 50 50 140 151
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 1, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.